Anixa Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Amit Kumar, with a market cap of $91.9M.
Common questions about Anixa Biosciences
Anixa Biosciences is scheduled to report earnings for Q2 2026 on May 27, 2026.
Anixa Biosciences has approximately 6 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.